Home › Essential Thrombocythemia › Ohio › Cleveland
Essential Thrombocythemia clinical trials in Cleveland, OH
3 studies for Essential Thrombocythemia are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- Cleveland Clinic Taussig Cancer Ctr, Cleveland
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Cleveland Clinic, Cleveland
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Cleveland Clinic, Cleveland
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Chicago, IL4 studies
- Boston, MA4 studies
- Baltimore, MD4 studies
- Nashville, TN4 studies
- Miami, FL4 studies
- Salt Lake City, UT4 studies
- Mountain View, CA4 studies
- Irvine, CA3 studies
- Los Angeles, CA3 studies
- Columbus, OH3 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer43 studies
- Cancer (all types)36 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Metastatic Cancer30 studies
- Ovarian Cancer30 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.